Last $0.0042 USD
Change Today 0.00 / 0.00%
Volume 0.0
RPBC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/16/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for redpoint bio corp (RPBC)

Year over year, Redpoint Bio Corporation has seen revenues shrink from $1.2M USD to $525.0K USD, though the company was able to grow net income from a loss of $5.5M USD to a smaller loss of $440.2K USD. A reduction in the percentage of sales devoted to income tax expense from -8.14% to -78.23% was a key component in the bottom line growth in the face of falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2008
Dec 31
2009
Dec 31
2010
Dec 31
2011
4 Year
Trend
Revenues4.01.91.20.5
TOTAL REVENUES4.01.91.20.5
Cost of Goods Sold8.65.63.01.0
GROSS PROFIT-4.6-3.8-1.8-0.5
Selling General & Admin Expenses, Total5.64.43.61.9
OTHER OPERATING EXPENSES, TOTAL5.64.43.61.9
OPERATING INCOME-10.3-8.2-5.4-2.4
Interest Expense-0.1-0.2-0.10.0
Interest and Investment Income0.60.10.00.0
NET INTEREST EXPENSE0.5-0.1-0.10.0
Other Non-Operating Income (Expenses)------0.9
EBT, EXCLUDING UNUSUAL ITEMS-9.8-8.3-5.6-1.6
Merger & Restructuring Charges---0.5----
Gain (Loss) on Sale of Assets------0.2
Other Unusual Items, Total------0.6
Other Unusual Items------0.6
EBT, INCLUDING UNUSUAL ITEMS-9.8-8.8-5.6-0.9
Income Tax Expense-0.3---0.1-0.4
Earnings from Continuing Operations-9.5-8.8-5.5-0.4
NET INCOME-9.5-8.8-5.5-0.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-9.5-8.8-5.5-0.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-9.5-8.8-5.5-0.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPBC:US $0.00 USD 0.00

RPBC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajinomoto Co Inc ¥1,624 JPY +11.50
GLG Life Tech Corp C$0.27 CAD 0.00
PureCircle Ltd 605.00 GBp 0.00
Symrise AG €39.99 EUR -0.47
Tate & Lyle PLC 638.00 GBp -11.50
View Industry Companies
 

Industry Analysis

RPBC

Industry Average

Valuation RPBC Industry Range
Price/Earnings 52.8x
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow 52.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REDPOINT BIO CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.